Bardo, M. ., Neisewander, J. ., & Ennis, R. . (1988). Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence. Neuropharmacology, 27(11), 1103-9. https://doi.org/10.1016/0028-3908(88)90004-4

Cheung, T. ., Nolan, B. ., Hammerslag, L. ., Weber, S. ., Durbin, J. ., Peartree, N. ., … Neisewander, J. . (2012). Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats. Neuropharmacology, 63(8), 1346-59. https://doi.org/10.1016/j.neuropharm.2012.08.011

Nolan, B. ., Liu, S. ., Hammerslag, L. ., Cheung, T. ., Lenz, J. ., Mach, R. ., … Neisewander, J. . (2013). Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine. Synapse (New York, N.Y.), 67(12), 847-55. https://doi.org/10.1002/syn.21691

Bardo, M. ., Neisewander, J. ., & Kelly, T. . (2013). Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacological Reviews, 65(1), 255-90. https://doi.org/10.1124/pr.111.005124

Bardo, M. ., Miller, J. ., & Neisewander, J. . (1984). Conditioned place preference with morphine: the effect of extinction training on the reinforcing CR. Pharmacology, Biochemistry, and Behavior, 21(4), 545-9. https://doi.org/10.1016/s0091-3057(84)80037-4

Bardo, M. ., Neisewander, J. ., & Miller, J. . Repeated testing attenuates conditioned place preference with cocaine. Psychopharmacology, 89(2), 239-43. https://doi.org/10.1007/BF00310636 (Original work published 1986)

Bardo, M. ., & Neisewander, J. . (1986). Single-trial conditioned place preference using intravenous morphine. Pharmacology, Biochemistry, and Behavior, 25(5), 1101-5. https://doi.org/10.1016/0091-3057(86)90092-4

Neisewander, J. ., & Bardo, M. . Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide. Psychopharmacology, 93(3), 314-9. https://doi.org/10.1007/BF00187249 (Original work published 1987)

Bardo, M. ., & Neisewander, J. . (1987). Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine. Pharmacology, Biochemistry, and Behavior, 28(2), 267-73. https://doi.org/10.1016/0091-3057(87)90224-3

Neisewander, J. ., Nonneman, A. ., Rowlett, J. ., & Bardo, M. . (1969). Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats. Neurobiology of Aging, 15(1), 91-7. https://doi.org/10.1016/0197-4580(94)90148-1 (Original work published 1969)